BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1695726)

  • 1. Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor.
    Kovar H; Dworzak M; Strehl S; Schnell E; Ambros IM; Ambros PF; Gadner H
    Oncogene; 1990 Jul; 5(7):1067-70. PubMed ID: 1695726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration.
    Ambros IM; Ambros PF; Strehl S; Kovar H; Gadner H; Salzer-Kuntschik M
    Cancer; 1991 Apr; 67(7):1886-93. PubMed ID: 1848471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and genetic characterization of the HBA71 Ewing's sarcoma cell surface antigen.
    Fellinger EJ; Garin-Chesa P; Su SL; DeAngelis P; Lane JM; Rettig WJ
    Cancer Res; 1991 Jan; 51(1):336-40. PubMed ID: 1988096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EWS rearrangement in Ewing's sarcoma and peripheral neuroectodermal tumor. Molecular detection and correlation with cytogenetic analysis and MIC2 expression.
    Ladanyi M; Lewis R; Garin-Chesa P; Rettig WJ; Huvos AG; Healey JH; Jhanwar SC
    Diagn Mol Pathol; 1993 Sep; 2(3):141-6. PubMed ID: 8287228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIC2 detection in tumors of bone and adjacent soft tissues.
    Devaney K; Abbondanzo SL; Shekitka KM; Wolov RB; Sweet DE
    Clin Orthop Relat Res; 1995 Jan; (310):176-87. PubMed ID: 7641436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2.
    Fellinger EJ; Garin-Chesa P; Triche TJ; Huvos AG; Rettig WJ
    Am J Pathol; 1991 Aug; 139(2):317-25. PubMed ID: 1867320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal rearrangement t(11;22) in extraskeletal Ewing's sarcoma and primitive neuroectodermal tumour analysed by fluorescence in situ hybridization using paraffin-embedded tissue.
    Nagao K; Ito H; Yoshida H; Minamizaki T; Furuse K; Yoshikawa T; Ushigome S
    J Pathol; 1997 Jan; 181(1):62-6. PubMed ID: 9072004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIC2 analysis in pediatric lymphomas and leukemias.
    Riopel M; Dickman PS; Link MP; Perlman EJ
    Hum Pathol; 1994 Apr; 25(4):396-9. PubMed ID: 8163272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ewing's sarcoma--routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study.
    Perlman EJ; Dickman PS; Askin FB; Grier HE; Miser JS; Link MP
    Hum Pathol; 1994 Mar; 25(3):304-7. PubMed ID: 8150461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma.
    Weidner N; Tjoe J
    Am J Surg Pathol; 1994 May; 18(5):486-94. PubMed ID: 7513503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic profile and FISH analysis in a case of Ewing's sarcoma.
    Papadopoulos N; Tamiolakis D; Lambropoulou M; Alexiadis G; Argyropoulou P; Manavis J; Verettas D; Sivridis E
    In Vivo; 2001; 15(4):359-64. PubMed ID: 11695230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a new human THY-1 related antigen in Ewing's sarcoma and peripheral neuroectodermal tumors.
    Hamilton G; Havel M; Mallinger R
    Immunol Lett; 1989 Sep; 22(3):205-9. PubMed ID: 2572544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIC2 analysis of small cell carcinoma.
    Lumadue JA; Askin FB; Perlman EJ
    Am J Clin Pathol; 1994 Nov; 102(5):692-4. PubMed ID: 7524308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a human endocrine tissue and tumor-associated Ewing's sarcoma antigen.
    Hamilton G; Fellinger EJ; Schratter I; Fritsch A
    Cancer Res; 1988 Nov; 48(21):6127-31. PubMed ID: 2844401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases.
    Zhang PJ; Barcos M; Stewart CC; Block AW; Sait S; Brooks JJ
    Mod Pathol; 2000 Apr; 13(4):452-8. PubMed ID: 10786814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory neuroblastoma and other round cell lesions of the sinonasal region.
    Devaney K; Wenig BM; Abbondanzo SL
    Mod Pathol; 1996 Jun; 9(6):658-63. PubMed ID: 8782204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of monomeric acrylic embedding media on the antigenicity of two epitopes of the MIC2-encoded Ewing's sarcoma cell membrane antigen.
    Hamilton G; Hamilton B; Mallinger R
    Histochemistry; 1992; 97(1):87-94. PubMed ID: 1377663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous Ewing's family sarcoma. Report of a case with immunostaining for glycoprotein p30/32 mic2.
    Sexton CW; White WL
    Am J Dermatopathol; 1996 Dec; 18(6):601-5. PubMed ID: 8989933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ewing's-sarcoma-associated HBA-71 tumor antigen represents a new differentiation marker of human thymocytes.
    Hamilton G; Mallinger R; Havel M
    J Cancer Res Clin Oncol; 1989; 115(6):592-6. PubMed ID: 2606935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product.
    Gelin C; Aubrit F; Phalipon A; Raynal B; Cole S; Kaczorek M; Bernard A
    EMBO J; 1989 Nov; 8(11):3253-9. PubMed ID: 2479542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.